Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Hexedrone

From PsychonautWiki Archive
Revision as of 14:12, 28 January 2017 by >Kenan (Reverted edits by Kaylee (talk) to last revision by Apx)
Jump to navigation Jump to search

Template:Proofread

Not to be confused with Ethyl-Hexedrone (n-ethyl-hexedrone, hexen).
Hexedrone
Chemical Nomenclature
Common names Hexedrone
Systematic name 2-(methylamino)-1-phenylhexan-1-one
Class Membership
Psychoactive class Stimulant
Chemical class Cathinone
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



⇣ Oral
Dosage
Threshold 30 mg
Light 50 - 70 mg
Common 70 - 100 mg
Strong 100 - 125 mg
Heavy 125 mg +
Duration
Total 1 - 4 hours
Onset 15 - 30 minutes
After effects 1 - 12 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions
Summary sheet: Hexedrone

Hexedrone is a research chemical stimulant that falls within the cathinone category. Considering its effects and its structure being closely related to Pentedrone, this too is likely to be an Norepinephrine-Dopamine-reuptake-inhibitor (NDRI). However, these assumptions have not already been confirmed, due to insufficient research.

Due to the lack of research along with only little experience-based information, the presented data might turn out to have some inaccuracies. This should especially be taken into consideration when interpreting the dosage information.

Chemistry

Hexedrone is a cathinone, which is closely related to amphetamines, but have a ß-substituted ketone group as well. Relative to regular cathinone, which can be found in the Khat plant, hexedrone consists of two added substitutions. At the R2 position, a n-Butyl substitution forms a hexan chain. The second substitution is a Methyl group, that's attached to the amine (R4), thus forming N-Methyl.

Pharmacology

Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based upon its structure and subjective effect similarities to other cathinones such as pentedrone and others. Hexedrone most likely acts as both a dopamine and norepinephrine reuptake inhibitor. This allows dopamine and norepinephrine to build up within the brain, resulting in stimulating and euphoric effects.

The decreased potency, compared to both pentedrone as well as ethyl-hexedrone can be easily explained. Compared to pentedrone, there's a larger non-polar side chain. Ethyl-hexedrone has an ethyl group, instead of a methyl, which results in a significantly shifted electronegativity.

Subjective effects

Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.

It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.

Physical effects

Cognitive effects

After effects

The effects which occur during the offset of a stimulant experience generally feel negative and uncomfortable in comparison to the effects which occurred during its peak. This is often referred to as a "comedown" and occurs because of neurotransmitter depletion. Its effects commonly include:

Toxicity and harm potential

Main article: Research chemicals § Toxicity and harm potential

Since hexedrone has been insufficiently studied and most data consists of speculation and user experiences, one should be cautious when it comes to the risks and harm. Especially long term effects could turn out to consist of serious health hazards. It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

As with other stimulants, the chronic use of Hexedrone can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage.

Tolerance to many of the effects of Hexedrone develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Hexedrone presents cross-tolerance with [[Cross-tolerance::all dopaminergic stimulants]], meaning that after the consumption of Hexedrone all stimulants will have a reduced effect.

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

  • UK - In the UK, Hexedrone is a Class B drug under The Misuse of Drugs Act 1971 (Amendment) Order 2010 following the ACMD's report on substituted cathinone derivatives,[1] making it illegal to sell, buy, or possess without a license.[2][3]

See also

References

  1. ↑ https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/119173/acmd-cathinodes-report-2010.pdf
  2. ↑ http://webarchive.nationalarchives.gov.uk/20130125102358/http://www.homeoffice.gov.uk/about-us/corporate-publications-strategy/home-office-circulars/circulars-2010/010-2010/
  3. ↑ http://www.legislation.gov.uk/uksi/2010/1207/article/2/made
Retrieved from "http://psy.st/w/index.php?title=Hexedrone&oldid=79918"